Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lovastatin in COPD
NCT00700921Phase 2Completed
- Sponsor
- National Jewish Health
- Start
- Apr 2008
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in chronic obstructive pulmonary disease (COPD) comparing Lovastatin with Placebo (2 arms). Primary endpoints: Effects of lovastatin on apoptosis in pulmonary macrophages at 5 years and Effects of lovastatin on efferocytosis in pulmonary macrophages at 5 years. Started Apr 2008; status: completed.
02
Drugs
lovastatin
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT00700921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00700921.